AICAR

AICAR (AICA ribonucleotide), also called 5-aminoimidazole-4-carboxamide ribonucleotide, is a cell-permeable nucleotide analog of AMP. In laboratory research it functions as a classic pharmacological tool for activating AMP-activated protein kinase (AMPK), the central cellular energy sensor. Investigators use AICAR to examine energy-sensing pathways and metabolic responses under controlled experimental conditions. It is supplied strictly for in-vitro and laboratory research use only.

Once taken up by cells, AICAR is phosphorylated to ZMP, which structurally mimics AMP and allosterically activates AMPK. Activated AMPK phosphorylates downstream targets that regulate glucose uptake, fatty-acid oxidation, and mitochondrial biogenesis. This approach allows researchers to study AMPK signaling without necessarily altering the endogenous AMP/ATP ratio. Parallel experiments help distinguish AMPK-dependent from AMPK-independent metabolic effects in model systems.

AICAR is employed to investigate cellular energy sensing, glucose transport, and fatty-acid oxidation pathways in cultured muscle cells and other in-vitro systems. Researchers also explore the transcriptional programs associated with endurance-like metabolic adaptation. The compound is widely used to dissect AMPK-dependent versus independent responses across metabolic networks. Additional studies focus on mitochondrial biogenesis and oxidative metabolism markers in experimental models.

Laboratory studies have demonstrated that AICAR elevates AMPK activity and increases glucose uptake in skeletal-muscle cell cultures. Parallel work has documented enhanced fatty-acid oxidation rates and upregulation of genes linked to oxidative capacity. These observations have helped map AMPK as a master regulator of cellular energy homeostasis. Findings consistently support its utility for probing metabolic signaling cascades in controlled research settings.

AICAR is intended exclusively for in-vitro and laboratory research applications. Standard laboratory practices for handling nucleotide analogs should be observed, including appropriate storage conditions and sterile technique. Experimental designs must account for possible off-target effects when attributing outcomes solely to AMPK activation. Researchers are advised to include suitable controls to confirm pathway specificity in each model system.